TRAW Traws Pharma, Inc.
Healthcare$1.58+6.04%ClosedMarket Cap: $14.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-2.99
P/S
0.00
EV/EBITDA
-0.74
DCF Value
$-7.73
FCF Yield
-18934.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
489.9%
ROA
-178.4%
ROIC
137635.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $0.00 | NaN% | $-6.95B | $-7.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-7.4M | $-7.4M | $— | — |
| FY null | $2.8M | 100.0% | $-17.9M | $9.2M | $— | — |
| Q2 null | $2.7M | 100.0% | $-1.2M | $-915.0K | $— | — |
| Q4 null | $57.0K | 96.5% | $-8.5M | $-8.5M | $— | — |
| FY null | $226.0K | 94.7% | $-49.3M | $-54.7M | $— | — |
| Q2 null | $56.0K | 100.0% | $-5.2M | $-5.0M | $— | — |
| Q4 null | $113.0K | 96.5% | $-9.6M | $-8.9M | $— | — |
| FY null | $226.0K | 100.0% | $-20.3M | $-18.9M | $— | — |
| Q2 null | $113.0K | 100.0% | $-10.7M | $-10.0M | $— | — |
| Q4 null | $113.0K | 96.5% | $-11.4M | $-10.8M | $— | — |
| FY null | $226.0K | 100.0% | $-19.6M | $-19.0M | $— | — |